Fortin, Stephen P.
Reps, Jenna
Ryan, Patrick
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 25 August 2022
Accepted: 13 September 2022
First Online: 7 October 2022
Change Date: 15 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12911-023-02205-4
Declarations
:
: Pursuant to Title 45 Code of Federal Regulations, Part 46 of the United States, specifically 45 CFR 46.104 (d)(4), retrospective analyses conducted in the DOD and MDCD are considered exempt from informed consent and institutional review board (IRB) approval in the United States. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: All authors are employees of Janssen Research and Development, LLC, a subsidiary of Johnson and Johnson. Stephen Fortin, Jenna Reps, and Patrick Ryan own stock in Johnson & Johnson.
: Review history available in Additional file .